Search Browse Earnings

EUPRAXIA PHARMACEUTICALS INC.

Nasdaq:EPRX

Pharmaceutical Preparations·VICTORIA, A1

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

EUPRAXIA PHARMACEUTICALS INC. — SlamSEC

Revenue

$0

FY 2023

Adj. EBITDA

—

Net Income

-$18.5M

FY 2023

EPS (Diluted)

-$0.96

FY 2023

Stock Price

$8.01

+0.8%

2026-03-06

52W Range

$2.68 – $9.32

P/E Ratio

-8.3x

Market Cap

$218.5M

Cash

$18.3M

FY 2023

Total Debt

—

Net Cash

$18.3M

FY 2023

Enterprise Value

$200.3M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—